Verition Fund Management
KURA icon

Verition Fund Management’s Kura Oncology KURA Stock Holding History

Verition Fund Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-150,000
Closed -$4.24M – 2023
2021
Q1 		$4.24M Buy
+150,000
New +$4.75M 0.05% 226

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Verition Fund Management's KURA Position: Q3 2025 in Review

Verition Fund Management sold out of Kura Oncology (KURA) in Q3 2025, closing a stake of 30,766 shares — an estimated $178K sold.

Verition Fund Management first reported a position in KURA in Q3 2020 and held it in 15 quarters. The position peaked at $9.86M in Q2 2022. 200 funds tracked by Wall St. Rank hold KURA as of Q3 2025.

  • Verition Fund Management reported no remaining Kura Oncology position as of Q3 2025 after selling out during the quarter.
  • Verition Fund Management sold 30,766 Kura Oncology shares in Q3 2025, an estimated $178K.
  • Verition Fund Management first reported a position in Kura Oncology in Q3 2020 and held it in 15 quarters.
  • Verition Fund Management's Kura Oncology position peaked at $9.86M in Q2 2022.
  • 200 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2025.

Based on Verition Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.